Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Synthetic globo H conjugate tested in breast cancer patients

May 2, 2001

ImClone Systems achieves milestone in BEC2 collaboration with Merck KGaA

April 30, 2001

New HspE7 data confirm earlier findings in anal dysplasia

April 26, 2001

Immune response boosted by MVA-BN melanoma vaccine

April 23, 2001

Cell Genesys commences phase I/II trial of high-potency GVAX

April 19, 2001

Titan's CeaVac and TriAb studied in combination with radiation therapy for NSCLC

April 17, 2001

Herceptin receives Japanese approval for treatment of metastatic breast cancer

April 5, 2001

FDA supports Vical's Allovectin-7 clinical development program

April 5, 2001

Clinical data reported for an optimized Theratope vaccine formulation

April 5, 2001

Renewed focus on oncology products at Transgene

April 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...